| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 17 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Computer technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Bioinformatics | |
| #5 | Computational chemistry | |
| #6 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lazar Gregory Alan | 17 |
| #2 | Karki Sher Bahadur | 14 |
| #3 | Dang Wei | 13 |
| #4 | Vafa Omid | 13 |
| #5 | Desjarlais John R | 8 |
| #6 | Hayes Robert | 7 |
| #7 | Vielmetter Jost | 6 |
| #8 | Chirino Arthur J | 5 |
| #9 | Desjarlais John | 5 |
| #10 | Hayes Robert J | 5 |
| Publication | Filing date | Title |
|---|---|---|
| US2015071948A1 | Novel immunoglobulin variants | |
| US2014370021A1 | OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION | |
| US2012225058A1 | Immunoglobulin insertions, deletions, and substitutions | |
| US2012128663A1 | Fc variants that extend antibody half-life | |
| US2007231329A1 | Fc variants | |
| US2007160597A1 | Optimized Fc variants and methods for their generation | |
| US2006024298A1 | Optimized FC variants |